Predictive Oncology Inc.
POAI
$6.00
$0.458.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,650.39% | 15.24% | -12.60% | 29.89% | 2.72% |
| Total Depreciation and Amortization | 2.52% | 2.53% | -71.04% | 262.58% | 1.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13,775.96% | -241.47% | 2,864.29% | -104.14% | -15.52% |
| Change in Net Operating Assets | 208.16% | -177.29% | 310.49% | 6.30% | 2.96% |
| Cash from Operations | 50.25% | -339.48% | 64.80% | 32.29% | 1.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -100.00% | 592.31% |
| Cash from Investing | -- | -100.00% | -- | -100.00% | 592.31% |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -146.91% | -108.68% |
| Issuance of Common Stock | 146.42% | -77.28% | -- | -100.00% | -65.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 69.05% | -54.45% | -- | 100.00% | 48.22% |
| Cash from Financing | 82.87% | -70.92% | 1,376.66% | -122.04% | -73.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.51% | -209.65% | 201.02% | -4.06% | -1,774.94% |